4//SEC Filing
WAGNER TODD R 4
Accession 0001066152-21-000003
CIK 0001591165other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 8:05 AM ET
Size
12.8 KB
Accession
0001066152-21-000003
Insider Transaction Report
Form 4
H-CYTE, INC.HCYT
WAGNER TODD R
10% Owner
Transactions
- Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+226,566,264$3,171,928→ 226,566,264 total(indirect: (SEE FOOTNOTE))From: 2020-09-24→ COMMON STOCK (226,566,264 underlying) - Other
STOCK PURCHASE WARRANTS
2020-09-24+265,868,613→ 265,868,613 total(indirect: (SEE FOOTNOTE))Exercise: $0.01From: 2020-09-24→ COMMON STOCK (265,868,613 underlying) - Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+110,219,286$1,543,070→ 336,785,550 total(indirect: (SEE FOOTNOTE))From: 2020-09-24→ COMMON STOCK (110,219,286 underlying)
FWHC BRIDGE, LLC
10% Owner
Transactions
- Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+226,566,264$3,171,928→ 226,566,264 total(indirect: (SEE FOOTNOTE))From: 2020-09-24→ COMMON STOCK (226,566,264 underlying) - Other
STOCK PURCHASE WARRANTS
2020-09-24+265,868,613→ 265,868,613 total(indirect: (SEE FOOTNOTE))Exercise: $0.01From: 2020-09-24→ COMMON STOCK (265,868,613 underlying) - Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+110,219,286$1,543,070→ 336,785,550 total(indirect: (SEE FOOTNOTE))From: 2020-09-24→ COMMON STOCK (110,219,286 underlying)
Footnotes (6)
- [F1]Held directly by FWHC Bridge, LLC (Bridge), and indirectly by Todd R. Wagner, the sole manager of Bridge. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
- [F2]Received upon conversion of variable conversion price notes at closing of Qualified Financing. Note conversion price became fixed at closing. "Price of derivative securities" represents aggregate price paid for debt divided by number of shares received upon conversion of debt. Series A stock is convertible into common stock on a 1:1 basis.
- [F3]Redeemable at option of requisite number of holders in specified circumstances.
- [F4]Received in connection with variable conversion price notes. No additional consideration was paid for warrants, Exercise price became fixed at closing of Qualified Financing.
- [F5]Purchased as part of backstop commitment in Qualified Financing. Series A stock is convertible into common stock on a 1:1 basis.
- [F6]Not applicable.
Documents
Issuer
H-CYTE, INC.
CIK 0001591165
Entity typeother
Related Parties
1- filerCIK 0001066152
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 8:05 AM ET
- Size
- 12.8 KB